Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Record History gains a new Revision: v3.7.0 entry. It also removes Revision: v3.6.6, updating the version history to reflect the latest change.
    Difference
    0.1%
    Check dated 2026-09-20T02:54:33.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 is added to the study record history, and the previous entry v3.6.5 is removed. This updates the page's version history to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-08-30T00:19:05.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry, v3.6.5. The previous revision, v3.6.4, is removed from the visible history, indicating an administrative update to the record version rather than substantive trial changes.
    Difference
    0.1%
    Check dated 2026-08-08T22:38:24.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the Record History. The prior v3.6.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-07-25T13:03:50.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study's record history. The previous revision, v3.6.2, was removed from the current history view.
    Difference
    0.1%
    Check dated 2026-07-03T23:56:26.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The Record History shows a new Revision: v3.6.2 entry replacing v3.6.0, representing a new software release for the study record interface.
    Difference
    0.1%
    Check dated 2026-06-26T23:19:34.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.